PIN27 ECONOMIC MODELLING TO DETERMINE THE COSTEFFECTIVENESS OF TREATMENT OF PATIENTS WITH HISTOLOGICALLY MILD CHRONIC HEPATITIS C WITH PEGYLATED INTERFERON ALPHA-2B PLUS RIBAVIRIN
Abstract
Authors
S Campbell S Norris P Mernagh R Batey GJ Dore